Research ArticleOriginal Article
Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
Winnie Yeo
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
2State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China
Leung Li
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
Thomas KH Lau
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
Kwai T Lai
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
Vicky TC Chan
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
Kwan H Wong
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
Christopher CH Yip
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
Elizabeth Pang
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
Maggie Cheung
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
Vivian Chan
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
Carol CH Kwok
3Department of Clinical Oncology, Princess Margaret Hospital, Hong Kong, China
Joyce JS Suen
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
Frankie KF Mo
1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China
2State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China
References
- 1.↵
- Coates A,
- Abraham A,
- Kaye SB,
- Sowerbutts T,
- Frewin C,
- Fox RM, et al.
- 2.↵
- Griffin AM,
- Butow PN,
- Coates AS,
- Childs AM,
- Ellis PM,
- Dunn SM, et al.
- 3.↵
- Lau TKH,
- Yip CHW,
- Yeo W.
- 4.↵
- 5.
- Herrstedt J,
- Roila F,
- Warr D,
- Celio L,
- Navari RM,
- Hesketh PJ, et al.
- 6.↵National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology. Antiemesis Version 1. 2020 https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf
- 7.↵
- Yeo W,
- Mo FK,
- Suen JJ,
- Ho WM,
- Chan SL,
- Lau W, et al.
- 8.↵
- Yeo W,
- Lau TK,
- Li L,
- Lai KT,
- Pang E,
- Cheung M, et al.
- 9.↵
- Yeo W,
- Lau TK,
- Kwok CC,
- Lai KT,
- Chan VT,
- Li L, et al.
- 10.↵
- Martin AR,
- Pearson JD,
- Cai B,
- Elmer M,
- Horgan K,
- Lindley C, et al.
- 11.↵
- Warr DG,
- Hesketh PJ,
- Gralla RJ,
- Muss HB,
- Herrstedt J,
- Eisenberg PD, et al.
- 12.↵
- Hashimoto H,
- Abe M,
- Tokuyama O,
- Mizutani H,
- Uchitomi Y,
- Yamaguchi T, et al.
- 13.↵
- Gralla RJ,
- Bosnjak SM,
- Hontsa A,
- Balser C,
- Rizzi G,
- Rossi G, et al.
- 14.↵
- Zhang L,
- Lu S,
- Feng J,
- Dechaphunkul A,
- Chang J,
- Wang D, et al.
- 15.↵
- Aapro M,
- Hesketh PJ,
- Jordan K,
- Gralla RJ,
- Rossi G,
- Rizzi G, et al.
- 16.↵
- 17.↵
- 18.
- 19.↵
- 20.↵
- Roscoe JA,
- Heckler CE,
- Morrow GR,
- Mohile SG,
- Dakhil SR,
- Wade JL, et al.
- 21.↵
- Aapro M,
- Fabi A,
- Nolè F,
- Medici M,
- Steger G,
- Bachmann C, et al.
- 22.↵
- Roila F,
- Ruggeri B,
- Ballatori E,
- Del Favero A,
- Tonato M.
- 23.↵
- 24.↵
- Kosaka Y,
- Tanino H,
- Sengoku N,
- Minatani N,
- Kikuchi M,
- Nishimiya H, et al.
- 25.↵
- Ito Y,
- Tsuda T,
- Minatogawa H,
- Kano S,
- Sakamaki K,
- Ando M, et al.
- 26.↵
- Okada Y,
- Oba K,
- Furukawa N,
- Kosaka Y,
- Okita K,
- Yuki S, et al.
- 27.↵
- Yokoe T,
- Hayashida T,
- Nagayama A,
- Nakashoji A,
- Maeda H,
- Seki T, et al.
In this issue
Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen, Frankie KF Mo
Cancer Biology & Medicine Aug 2021, 18 (3) 825-832; DOI: 10.20892/j.issn.2095-3941.2020.0241
Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen, Frankie KF Mo
Cancer Biology & Medicine Aug 2021, 18 (3) 825-832; DOI: 10.20892/j.issn.2095-3941.2020.0241
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.